Skip to main content
logo
BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
3.090
-0.360 (-10.43%)
At close: Aug 14, 2026, 4:00 PM EDT
3.110
+0.020 (0.65%)
After-hours: Aug 14, 2026, 7:34 PM EDT

BioAtla Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2211--0.25
Revenue Growth
-81.82%-81.82%----41.73%
Gross Profit
-32.9-41.07-52.1-103.73-79.35-58.02
Operating Income
-49.9-58.71-73.94-129.69-108.14-96.44
Net Income
-50.62-59.61-69.78-123.46-106.48-95.4
Earnings Per Share
-40.15-50.66-71.83-129.21-136.77-138.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.967.1249.05111.47215.51244.98
Total Debt
6.096.20.842.463.985.37
Net Cash (Debt)
-4.130.9248.21109.01211.53239.61
Net Cash Growth
--98.10%-55.77%-48.46%-11.72%0.71%
Net Cash Per Share
-3.280.7849.63114.08271.69346.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-37.18-48.2-71.94-104.02-90.42-62.21
Capital Expenditures
----0.1-0.27-0.92
Free Cash Flow
-37.18-48.2-71.94-104.11-90.69-63.14
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------
Operating Margin
-2494.95%-2935.25%-672.21%---38576.00%
Pretax Margin
-2530.85%-2980.35%-634.33%---38160.80%
Profit Margin
-2530.85%-2980.35%-634.33%---38160.80%
FCF Margin
-1859.15%-2410.20%-653.96%---25255.20%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
0.6016.763.12--8633.02